Journal of Experimental Pathology
ISSN: 2694-5061

Commentary - Journal of Experimental Pathology (2020) Volume 1, Issue 1

Pancytopenia: An Update

Subhashish Das*

Professor, Department of Pathology, Sri Devaraj Urs Medical College, Tamaka, Kolar, Karnataka, India

*Corresponding Author:
Subhashish Das

Received date: August 05, 2020; Accepted date: September 02, 2020

Citation: Das S. Pancytopenia: An Update. J Exp Pathol 2020; 1(1): 28-32.

Copyright: © 2020 Das S. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Peripheral pancytopenia is not a disease by itself; rather it describes simultaneous presence of anemia, leucopenia and thrombocytopenia resulting from a number of disease processes. Detailed clinical history and meticulous physical examination along with baseline hematological investigations, provides invaluable information in the complete workup of pancytopenic patients, helping in systematic planning of further investigations to diagnose and ascertain the cause, avoiding a battery of unnecessary tests [1].

Peripheral pancytopenia is reduction in all three major formed elements of blood to levels below their lower normal limit leading to simultaneous presence of anemia, leucopenia and thrombocytopenia [2]. Thus, it is not a disease entity by itself, but rather a triad of findings. As the severity of pancytopenia and the underlying pathology determines the management and prognosis of these patients, identifying the correct etiopathology in a given case is crucial and helps in implementing timely and appropriate treatment [3].

Detailed clinical history and meticulous physical examination along with baseline hematological investigations provide invaluable information in the evaluation of pancytopenic patients, helping in systematic planning of further investigations to diagnose and ascertain the cause, avoiding unnecessary tests which not only add to the expense of treatment but sometimes also may result in delayed diagnoses and treatment [4].

As a large proportion of causes for pancytopenia are treatable and reversible, accurate diagnoses and timely intervention maybe lifesaving and will certainly have impact on the morbidity and mortality in these vulnerable patients. Knowing the exact etiology is thus important for specific and timely treatment and for prognostication [5].

A pre-designed proforma should be used to record history, examination details and investigation reports in a systematic manner. All patients should be thoroughly examined with special attention on history of prior drug intake, exposure to chemical agents and radiation either by occupational, accidental or by medical treatment. History of recent viral infections, fever, weight loss, bleeding from various sites (gums, nose, mouth, vagina) should be noted. Dietary history in detail including on type of food, intake animal products e.g. meat milk, eggs should be taken. History of abdominal pain and bowel habits should be noted. History of previous blood transfusions should be noted. A detailed meticulous physical examination of every patient should be done for pallor, icterus, pedal oedema, mouth ulcers, hepatosplenomegaly, lymphadenopathy, sternal tenderness, and gum hypertrophy should be done. Evidence of hypersplenism and primary malignancy should be searched wherever necessary [7].

The laboratory analysis includes Complete Blood Count (CBC) with absolute values should be conducted on an automated blood analyzer. All hematological parameters should be obtained. Values of hemoglobin, red blood cell count, total leucocyte count, differential leucocyte count, platelet count, Mean Corpuscular Volume (MCV), Mean Corpuscular Hemoglobin (MCH), Mean Corpuscular Hemoglobin Concentration (MCHC), Packed Cell Volume (PCV) and reticulocyte count should be noted and analyzed [8].

Peripheral blood smear examination should be done systematically under low, high and oil immersion microscope for RBC morphology i.e., microcytosis, macrocytosis, anisocytosis, poikilocytosis, polychromasia, nucleated red blood cells and presence of inclusions. Differential leucocyte count should be done. Neutrophils should be studied in detail for defective granulation and hyper segmentation. Platelet count and morphology should be analyzed. Bone marrow aspiration studies along with trephine biopsy should be done wherever indicated from anterior superior iliac spine using standard methods and under all aseptic precautions after obtaining written consent from the patient or guardian. The bone marrow aspiration smears and the biopsy sections should be studied in detail. As and when required, bone marrow aspiration and bone marrow biopsy slides should be stained with Perl’s stain, periodic acid Schiff stain, Zeihl– Neelsen stain or Reticulin stain [9].

Iron profile (serum iron and ferritin), serum folic acid and serum vitamin B12 level should be done in all cases.

Other investigations should be performed as and when indicated which includes erythrocyte sedimentation rate, liver function tests, renal function tests, serological investigations for enteric fever, blood culture, ELISA for HIV, hepatitis B and C viruses and serum protein E electrophoresis. Urine examination including, urinary Bence Jones proteins and stool examination should be advised depending on the case. Chest and bone radiographs, abdominal and pelvis ultrasonography must be carried out. The investigative work up being directed by the pancytopenia profile developed by us and the suspected underlying pathology [10].


Pancytopenia is a common hematological entity encountered in our day to day clinical practice. This should put the physicians on high alert demanding further investigations to look for the possible cause. Since the underlying pathology determines the management and prognosis of these patients, identification of the cause is crucial. Pancytopenia and aplastic anaemia are not synonymous anymore as was thought earlier. There is a definite change in trend from aplastic to megaloblastic anaemia over the years. Megaloblastic anaemia is quite common in Indian population possibly due to nutritional factors and is easily reversible with appropriate treatment. Thus, megaloblastic anaemia should always be considered in the evaluation of pancytopenia in Indian and other Asian countries.

The evaluation of patient with pancytopenia requires a holistic approach and the proper identification of the underlying cause remains a challenge because of variable etiopathological factors and inheritable conditions. Recent advances in molecular pathology including genomic profiling and next generation sequencing has great potential in providing cost effective diagnostic options in such cases and needs to be explored with proper emphasis [11].